Kadcyla

Last modified on March 19, 2013 at 9:30 am

---

Kadcyla (chemical name: T-DM1) is approved by the U.S. Food and Drug Administration to treat HER2-positive metastatic breast cancer that has previously been treated with Herceptin (chemical name: trastuzumab) and a taxane chemotherapy.

In this section you can learn more about:

• How Kadcyla Works
• Will Kadcyla Work for You?
• What to Expect When Taking Kadcyla
• Kadcyla Side Effects